Semaglutide, the active ingredient in the obesity treatment ‘Wegovy’ and diabetes medication ‘Ozempic,’ has shown anti-aging ...

Semaglutide is an injectable drug formulated for the treatment of type 2 diabetes, but it’s since become increasingly popular as a weight loss treatment. While the drug—commonly known by brand names ...

Ozempic may work in the brain in almost the opposite way scientists expected, activating hunger-linked neurons that appear ...

New research shows people with type 2 diabetes and chronic kidney disease who took semaglutide (commonly sold as Ozempic) once a week had improved kidney outcomes, even if they had heart disease or a ...

Mice treated with semaglutide showed improved muscle and cognitive function, reduced inflammation, had better memory and ...

Ozempic, Wegovy, Zepbound, and Mounjaro users may notice increased hair shedding, but rapid weight loss and reduced food ...

The injectable medication known for weight loss and diabetes treatment may even have benefits for mental health conditions, ...

Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still ...

PLAINSBORO, N.J., Jan. 28, 2025 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic® to reduce the risk of kidney disease worsening, ...

Medicare's drug price negotiation made headlines, but the number getting passed around tells only part of the story for ...

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Semaglutide Market Size, Share & Trends Analysis Report by Product (Ozempic, Wegovy, Rybelsus), Application (Type 2 Diabetes Mellitus, Obesity), Route of ...